Fight Back Give Back with Clinical Trials
By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 24 February 2019 In News, Science
When patients understand all of their options, including clinical trials, they can make informed decisions about their care. For many patients, clinical trials represent the best possible way to get access to cutting-edge treatment options.
Overcoming Targeted Therapy Resistance
Targeted therapies work well for many patients, but most will go on to develop acquired resistance. Researchers are working to address this challenge. Learn about two promising examples.
It’s Not that Simple: Young Women and Melanoma
By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 15 February 2019 In Prevention, Science
Article after article describes the ‘skyrocketing’ increases in melanoma among young women. While most are quick to point out the clear association between intentional tanning and skin cancer, few ever hint that there may be more to the story.
When Are Melanoma Patients Finished with Immunotherapy?
By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 23 January 2019 In Melanoma Stories, Science, Treatment
For melanoma patients, deciding when to discontinue treatment is a difficult decision. should the general ‘rule of thumb’ of treating patients with advanced disease until progression still apply? According to Dr. Jeffrey Weber and the data he presented at the European Society for Medical Oncology (ESMO) Congress late last year, the answer is maybe not.
Melanoma Treatment Advances – 2018 in Review
2018 brought new and expanded drug approvals that give patients, doctors, and their families more treatment options with fewer side effects. Learn more about important melanoma treatment advances in 2018.
From Health Scare to Transformative Change
By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 16 January 2019 In Melanoma Stories
Debra Black founded the Melanoma Research Alliance in 2007 after her own diagnosis with Stage II disease earlier that year. Since then, MRA has become the largest, non-profit funder of melanoma research worldwide.
Make Your Sun Safety Habit Stick: La Roche Posay’s My Skin Track UV
Last month’s arrival of La Roche Posay’s My Skin Track UV may be just what the doctor ordered to help people understand the danger of overexposure to ultraviolet radiation.
MRA Advisor & Grantee Dr. Allison Awarded Nobel Prize for Transforming Cancer Care
By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 28 November 2018 In News, Science, Treatment
MRA Scientific Advisory Panel Member & Grantee Dr. Allison Awarded Nobel Prize for his pioneering research to harness the power of the immune system to attack cancer. His work in immunotherapy, which began in the 1990’s, was audacious at the time. It helped to mainstream an entirely new class of tools in the arsenal against cancer; joining the likes of chemotherapy, radiation, and surgery.
Dr. Marc Hurlbert Joins MRA as Chief Science Officer
By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 20 November 2018 In Science
Dr. Marc Hurlbert has built his career advancing medical research in support of patients. Now, as of this month, he will translate his skills, relationships, and enthusiasm to achieving our mission of ending death and suffering due to melanoma as MRA’s Chief Science Officer.